PET and fluorescent imaging for prostate cancer surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new imaging agent that may help surgeons see prostate cancer more clearly during surgery, potentially leading to more complete removal of the cancer. You may be eligible if you are scheduled for prostate cancer surgery and have not had prior treatment for your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer.
- You are 18 years or older.
- Your cancer has not spread to distant parts of the body (like bones or other organs), but it may have spread to local lymph nodes.
- You are scheduled to have surgery to remove your prostate.
- You have not had prior treatment for prostate cancer, such as hormone therapy, chemotherapy, radiation, or surgery for the cancer.
- You are willing to undergo PET/CT scans and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET scan called XACP3 to see if it can find prostate cancer as well as the standard PSMA PET scan. You could help by having both scans to compare them.
This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.
This trial tests a new type of PET scan using a radioactive tracer called [68Ga]DOTA-IR-780-C-4 to see if it can find prostate cancer cells that express a protein called PSMA. If you have advanced prostate cancer that has stopped responding to standard treatments, this scan may help your doctor better understand your cancer and possibly guide future care.
This study compares two types of special imaging scans (PET/CT scans) to see which one better detects prostate cancer or its recurrence. You would undergo both scans as part of the research to help doctors improve how they find and treat prostate cancer.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
This study tests a new imaging method (PET scan) that uses a special tracer to find prostate cancer cells, whether it's the first diagnosis or a recurrence after treatment. The goal is to see how well this imaging works for locating cancer in the body.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.